SNCA and Parkinson disease: Interestingly, it has been reported that mannitol treatment can reverse some behaviour phenotypes in an in vivo model of PD (D. melanogaster), and most importantly can also reduce accumulation of α-synuclein in the brain of a transgenic mouse model of the disease [196].